5.06
price down icon1.75%   -0.09
pre-market  Vorhandelsmarkt:  5.05   -0.010   -0.20%
loading

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.82%
3.7521
3.0802 3.3084 2.6542 2.5514
Operating Expenses
21.20%
5.311
4.3819 4.5021 3.9398 3.7749
Interest Income/Expense
1.11%
0.1247
0.1233 0.126 0.126 0.1247
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
21.20%
5.311
4.3819 4.5021 3.9398 3.7749
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
19.75%
-1.5589
-1.3017 -1.1937 -1.2857 -1.2236
Income/Loss From Continuing Operations Before Tax
387.26%
3.7521
-1.3062 3.3084 2.6542 -1.2672
Income/Loss From Continuing Operations After Tax
20.27%
-1.571
-1.3062 -1.1928 -1.3124 -1.2672
Net Income/Loss
20.27%
-1.571
-1.3062 -1.1928 -1.3124 -1.2672
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
2.5532
2.5487 0.5234 1.3999 1.3635
Diluted Average Shares
0.18%
2.5532
2.5487 0.5234 1.3999 1.3635
Basic Earnings Per Share
21.57%
-0.62
-0.51 0.20 -0.94 -0.93
Diluted Earnings Per Share
21.57%
-0.62
-0.51 0.20 -0.94 -0.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.75
price up icon 1.13%
$9.71
price up icon 1.15%
$53.25
price down icon 4.91%
drug_manufacturers_specialty_generic RDY
$14.44
price down icon 0.48%
$146.67
price up icon 0.18%
$438.75
price up icon 1.08%
Kapitalisierung:     |  Volumen (24h):